☆ 4.7 Editorial Material

Editorial: autoimmune hepatitis and metabolic syndrome-associated disease development-an important question but only part of the answer?

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Autoimmune hepatitis and metabolic syndrome-associated disease development: a US cohort study

Muhammad I. Jalal et al.

Summary: This study found that patients with autoimmune hepatitis (AIH) are at a higher risk of developing metabolic syndrome-associated diseases (MSADs), possibly due to the long-term use of corticosteroid therapy and general population trends. The initial treatment regimen was found to affect the development of new-onset diabetes, and the presence of MSADs was associated with lower rates of biochemical remission in AIH patients.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Add to Collection

Letter Medicine, General & Internal

Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016

Grishma Hirode et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Medicine, General & Internal

Hepatic steatosis is highly prevalent but is not correlated with stiffness in autoimmune hepatitis

Sai Chalasani et al.

MEDICINE (2020)

Add to Collection

Article Gastroenterology & Hepatology

Adverse events related to low dose corticosteroids in autoimmune hepatitis

Floris F. van den Brand et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

Add to Collection

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver disease in patients with autoimmune hepatitis

Atsushi Takahashi et al.

JGH OPEN (2018)

Add to Collection

Review Cardiac & Cardiovascular Systems

Metabolic syndrome: pathophysiology, management, and modulation by natural compounds

Yogita Rochlani et al.

THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE (2017)

Add to Collection

Review Gastroenterology & Hepatology

Autoimmune hepatitis: current challenges and future prospects

Yoshio Aizawa et al.

CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease

Javier De Luca-Johnson et al.

DIGESTIVE DISEASES AND SCIENCES (2016)

Add to Collection

Article Gastroenterology & Hepatology

Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study

Maria Stepanova et al.

GUT (2010)

Add to Collection

Review Gastroenterology & Hepatology

Treatment options for autoimmune hepatitis: A systematic review of randomized controlled trials

Mieke M. H. Lamers et al.

JOURNAL OF HEPATOLOGY (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.